In the last trading session, 1.15 million Angiodynamic Inc (NASDAQ:ANGO) shares changed hands as the company’s beta touched 0.54. With the company’s per share price at $11.80 changed hands at -$0.66 or -5.30% during last session, the market valuation stood at $477.49M. ANGO’s last price was a discount, traded about -11.27% off its 52-week high of $13.13. The share price had its 52-week low at $5.26, which suggests the last value was 55.42% up since then. When we look at Angiodynamic Inc’s average trading volume, we note the 10-day average is 1.11 million shares, with the 3-month average coming to 621.84K.
Analysts gave the Angiodynamic Inc (ANGO) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 0 out of 3 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended ANGO as a Hold, 3 felt it is a Buy and 0 rated the stock as Underweight. Angiodynamic Inc’s EPS for the current quarter is expected to be -0.13.
Angiodynamic Inc (NASDAQ:ANGO) trade information
Instantly ANGO was in red as seen at the end of in last trading. With action 27.29%, the performance over the past five days has been green. The company’s shares are showing year-to-date upside of 28.82%, with the 5-day performance at 27.29% in the green. However, in the 30-day time frame, Angiodynamic Inc (NASDAQ:ANGO) is 29.53% up. Looking at the short shares, we see there were 1.0 million shares sold at short interest cover period of 1.8 days.
The consensus price target for the stock as assigned by Wall Street analysts is 13, meaning bulls need an upside of 9.23% from its current market value. According to analyst projections, ANGO’s forecast low is 12 with 14 as the target high. To hit the forecast high, the stock’s price needs a -18.64% plunge from its current level, while the stock would need to soar -1.69% for it to hit the projected low.
Angiodynamic Inc (ANGO) estimates and forecasts
Data shows that the Angiodynamic Inc share is performing relatively much not better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot 98.99% over the past 6 months, a -7.89% in annual growth rate that is considerably lower than the industry average of 14.90%. Year-over-year growth is forecast to reach -6.25% down from the last financial year.
Consensus estimates given by 3 financial analysts project the company’s revenue in the current quarter to hit an average of 70.3M. 3 analysts are of the opinion that Angiodynamic Inc’s revenue for the current quarter will be 74.23M. The company’s revenue for the corresponding quarters a year ago was 65.97M and 70.98M respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at 6.56%. The estimates for the next quarter sales put growth at 4.58%.
The 2025 estimates are for Angiodynamic Inc earnings to increase by 2.63%.
ANGO Dividends
Angiodynamic Inc is expected to release its next quarterly earnings report in February.
Angiodynamic Inc (NASDAQ:ANGO)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 5.60% of Angiodynamic Inc shares while 81.30% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 86.13%. There are 81.30% institutions holding the Angiodynamic Inc stock share, with BLACKROCK INC. the top institutional holder. As of 2024-06-30, the company held 11.4443% of the shares, roughly 4.6 million ANGO shares worth $27.86 million.
VANGUARD GROUP INC holds the second largest percentage of outstanding shares, with 5.4418% or 2.19 million shares worth $13.25 million as of 2024-06-30.
Among Mutual Funds, the top two as of Sep 30, 2024 were Vanguard Total Stock Market Index Fund and iShares Russell 2000 ETF . With 1.2 shares estimated at $14.15 million under it, the former controlled 2.96% of total outstanding shares. On the other hand, iShares Russell 2000 ETF held about 2.44% of the shares, roughly 985.55 shares worth around $11.63 million.
